1887

Abstract

Summary

Recombinant DNA methodology has allowed the production of human fibroblast interferon (IFN-β) from and this material, in highly purified form, has been shown to reduce viraemia and mortality in encephalomyocarditis (EMC) virus-infected squirrel monkeys. These effects are dose related: six treatments over 4 days at 10 U/kg and 3 × 10 U/kg have comparable efficacy, whereas treatments at 10 U/kg are ineffective. The recombinant DNA-derived IFN-β appears to be as effective as natural fibroblast cell-derived IFN-β and both materials are effective by the intramuscular or intravenous routes. Thus, even though previous studies have shown that low circulating concentrations of IFN-β are observed after intramuscular injections, the present data indicate that this slow release from the muscle can still confer protection.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-64-2-415
1983-02-01
2019-10-21
Loading full text...

Full text loading...

http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-64-2-415
Loading

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error